RSP Systems closes Series B, bringing total funding to US$28 million

RSP Systems has completed its Series B at a total amount of US$15.5 million to accelerate regulatory approval and manufacturing of the GlucoBeam, a novel device that offers convenient and accurate noninvasive glucose monitoring for people with diabetes. RSP Systems A/S has received an additional US$3.3 million in financing from several key investors. The Series B closed at US$15.5 […]